NCT00004695View on ClinicalTrials.gov

Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency

NACompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

September 30, 1997

Study Completion Date

March 31, 2000

Conditions

Common Variable Immunodeficiency

Interventions

DRUG

PEG-interleukin-2

All Listed Sponsors

lead

Icahn School of Medicine at Mount Sinai

OTHER